QXL · Quantum X Labs Inc. · Insider Trading

The reported price is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $4.88 to $4.97 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

The price reported is a weighted average price. The reported securities were purchase in multiple transactions at prices ranging from $4.70 to $4.88. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.

These securities are held by Yoresh Capital Ltd. The Reporting Person is the officer, sole director, chairman of the board of directors and controlling shareholder of Yoresh Capital Ltd. In such capacity, the Reporting Person may be deemed to beneficially own the reported securities. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purposes.

On May 31, 2026, the Reporting Person exercised a pre-funded warrant to purchase 88,675 shares of common stock of Quantum X Labs Inc. The Reporting Person paid the exercise price on a cashless basis, which did not result in the withholding of any shares.

The Pre-Funded Warrants will not expire until exercised in full.

The Pre-Funded Warrants will not expire until exercised in full.

On May 31, 2026, the Reporting Person exercised a pre-funded warrant to purchase 246,387 shares of common stock of Quantum X Labs Inc. The Reporting Person paid the exercise price on a cashless basis, which did not result in the withholding of any shares.

The reporting person is the officer, sole director, chairman of the board of directors and controlling shareholder of Amitay Weiss Management Ltd.

On March 4, 2026, the Reporting Person acquired (i) 179,159 shares of common stock of Viewbix Inc. ("Common Stock") and (ii) pre-funded warrants (the "Pre-Funded Warrants") to purchase up to 88,675 shares of Common Stock, in exchange for the Reporting Person's shares in Quantum X Labs Ltd. ("Quantum"), pursuant to a Securities Exchange Agreement dated December 15, 2025 by and between the Issuer, Quantum and shareholders of Quantum, which included the Reporting Person (the "Securities Exchange Agreement'). The transactions contemplated by the Securities Exchange Agreement were pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended.

On March 4, 2026, the Reporting Person acquired (i) 179,159 shares of common stock of Viewbix Inc. ("Common Stock") and (ii) pre-funded warrants (the "Pre-Funded Warrants") to purchase up to 88,675 shares of Common Stock, in exchange for the Reporting Person's shares in Quantum X Labs Ltd. ("Quantum"), pursuant to a Securities Exchange Agreement dated December 15, 2025 by and between the Issuer, Quantum and shareholders of Quantum, which included the Reporting Person (the "Securities Exchange Agreement'). The transactions contemplated by the Securities Exchange Agreement were pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended.

The Pre-Funded Warrants will not expire until exercised in full.

This transaction involved the Reporting Person's gift of 100,000 shares of the Issuer's common stock to his son. The Reporting Person disclaims beneficial ownership of the securities held by his son, and this Form 4 shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

The shares of common stock reported in this row represent shares of restricted stock that were acquired in a private placement transaction on September 3, 2025, pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Private Placement").

The purchase price per share of common stock in the Private Placement was $1.00.

The shares of common stock reported in this row represent shares of restricted stock that were acquired in a private placement transaction on July 11, 2025, pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Private Placement").

The purchase price per share of common stock and associated common warrant in the Private Placement was $4.86.

The warrants to purchase common stock (the "Warrants") reported in this row represent Warrants that were acquired in the Private Placement.

The shares of common stock reported in this row represent shares of restricted stock that were acquired in a private placement transaction on July 11, 2025, pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Private Placement").

The shares of common stock reported in this row represent shares of that were acquired by the Reporting Person as a gift for no consideration.

The warrants to purchase common stock, par value $0.0001 per share was issued by the Company to the reporting person, upon the conversion of outstanding interest, at a conversion rate of $1.00 due under a loan provided by the reporting person pursuant to the Facility Agreement.

Includes a warrant to purchase 5,000 shares of common stock, par value $0.0001 per share, that was previously issued by the Company to the reporting person, which is currently exercisable or exercisable within 60 days of March 21, 2025.

The shares of common stock were issued by the Company to the reporting person upon the conversion of outstanding interest, at a conversion rate of $1.00, due under a loan provided by the reporting person pursuant to the facility agreement between the Company, the reporting person and the other lenders listed therein (the "Facility Agreement").

Includes (i) 27,778 shares of common stock, par value $0.0001 per shares that was previously issued to the reporting person and (ii) a warrant to purchase 5,000 shares of common stock, par value $0.0001 per share, that was previously issued by the Company to the reporting person, which is currently exercisable or exercisable within 60 days of March 21, 2025, held by Amitay Weiss Management Ltd.

The reporting person is the officer, sole director, chairman of the board of directors and controlling shareholder of Amitay Weiss Management Ltd.

The warrants to purchase common stock, par value $0.0001 per share was issued by the Company to the reporting person, upon the conversion of outstanding interest, at a conversion rate of $1.00 due under a loan provided by the reporting person pursuant to the Facility Agreement.

Includes a warrant to purchase 18,750 shares of common stock, par value $0.0001 per share, that was previously issued by the Company to the reporting person, which is currently exercisable or exercisable within 60 days of March 21, 2025.

The warrants to purchase common stock, par value $0.0001 per share was issued by the Company to the reporting person, upon the conversion of outstanding interest, at a conversion rate of $1.00 due under a loan provided by the reporting person pursuant to the Facility Agreement.

Includes (i) 2,568 shares of common stock, previously issued to the reporting person and (ii) a warrant to purchase 5,000 shares of common stock, par value $0.0001 per share, that was previously issued by the Company to the reporting person, which is currently exercisable or exercisable within 60 days of March 21, 2025 held by Yoresh Capital Ltd.

Eli Yoresh is the officer, sole director, chairman of the board of directors and controlling shareholder of Yoresh Capital Ltd.

The warrants to purchase common stock, par value $0.0001 per share was issued by the Company to the reporting person, upon the conversion of outstanding interest, at a conversion rate of $1.00 due under a loan provided by the reporting person pursuant to the Facility Agreement.

Includes (i) 27,778 shares of common stock, par value $0.0001 per shares that was previously issued to the reporting person and (ii) a warrant to purchase 5,000 shares of common stock, par value $0.0001 per share, that was previously issued by the Company to the reporting person, which is currently exercisable or exercisable within 60 days of March 21, 2025, held by Amitay Weiss Management Ltd.

The reporting person is the officer, sole director, chairman of the board of directors and controlling shareholder of Amitay Weiss Management Ltd.

The shares of common stock were issued by the Company to the reporting person upon the conversion of outstanding interest, at a conversion rate of $1.00, due under a loan provided by the reporting person pursuant to the facility agreement between the Company, the reporting person and the other lenders listed therein (the "Facility Agreement").

Includes a warrant to purchase 2,500 shares of common stock, par value $0.0001 per share, that was previously issued by the Company to the reporting person, which is currently exercisable or exercisable within 60 days of March 21, 2025.

The shares of common stock were issued by the Company to the reporting person upon the conversion of outstanding interest, at a conversion rate of $1.00, due under a loan provided by the reporting person pursuant to the facility agreement between the Company, the reporting person and the other lenders listed therein (the "Facility Agreement").

Includes a warrant to purchase 18,750 shares of common stock, par value $0.0001 per share, that was previously issued by the Company to the reporting person, which is currently exercisable or exercisable within 60 days of March 21, 2025.

The shares of common stock were issued by the Company to the reporting person upon the conversion of outstanding interest, at a conversion rate of $1.00, due under a loan provided by the reporting person pursuant to the facility agreement between the Company, the reporting person and the other lenders listed therein (the "Facility Agreement").

Includes a warrant to purchase 5,000 shares of common stock, par value $0.0001 per share, that was previously issued by the Company to the reporting person, which is currently exercisable or exercisable within 60 days of March 21, 2025.

The shares of common stock were issued by the Company to the reporting person upon the conversion of outstanding interest, at a conversion rate of $1.00, due under a loan provided by the reporting person pursuant to the facility agreement between the Company, the reporting person and the other lenders listed therein (the "Facility Agreement").

Includes (i) 2,568 shares of common stock, previously issued to the reporting person and (ii) a warrant to purchase 5,000 shares of common stock, par value $0.0001 per share, that was previously issued by the Company to the reporting person, which is currently exercisable or exercisable within 60 days of March 21, 2025 held by Yoresh Capital Ltd.

Eli Yoresh is the officer, sole director, chairman of the board of directors and controlling shareholder of Yoresh Capital Ltd.

The warrants to purchase common stock, par value $0.0001 per share was issued by the Company to the reporting person, upon the conversion of outstanding interest, at a conversion rate of $1.00 due under a loan provided by the reporting person pursuant to the Facility Agreement.

Includes a warrant to purchase 2,500 shares of common stock, par value $0.0001 per share, that was previously issued by the Company to the reporting person, which is currently exercisable or exercisable within 60 days of March 21, 2025.

The warrant to purchase common stock, par value $0.0001 per share, was issued by the Company to the reporting person pursuant to a loan agreement between Viewbix Ltd., a wholly owned subsidiary of the Company, the reporting person and the other lenders listed therein.

The reporting person is the sole director and officer of Yoresh Capital Ltd. The reporting person has a beneficial ownership interest in Yoresh Capital Ltd.

The warrant to purchase common stock, par value $0.0001 per share, was issued by the Company to the reporting person pursuant to a loan agreement between Viewbix Ltd., a wholly owned subsidiary of the Company, the reporting person and the other lenders listed therein.

The warrant to purchase common stock, par value $0.0001 per share, was issued by the Company to the reporting person pursuant to a loan agreement between Viewbix Ltd., a wholly owned subsidiary of the Company, the reporting person and the other lenders listed therein.

The reporting person is the sole director and officer of Amitay Wiss Management Ltd. The reporting person has a beneficial ownership interest in Amitay Wiss Management Ltd.

The warrant to purchase common stock, par value $0.0001 per share, was issued by the Company to the reporting person pursuant to a loan agreement between Viewbix Ltd., a wholly owned subsidiary of the Company, the reporting person and the other lenders listed therein.

The warrant to purchase common stock, par value $0.0001 per share, was issued by the Company to the reporting person pursuant to a loan agreement between Viewbix Ltd., a wholly owned subsidiary of the Company, the reporting person and the other lenders listed therein.

The shares of Common Stock were issued by the Company to the reporting person as a special bonus equity grant, with an aggregate value of $100,000 and a price per share of $0.90, which is equal to the fair market value of the Company's common stock as of May 18, 2023, the date of the approval by the Board of Directors.

Includes (i) 11,274,334 of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), (ii) warrants to purchase up to 130,333 shares of Common Stock with an exercise price of $0.48 per share, each of such warrant is currently exercisable or exercisable within 60 days of October 3, 2022, and (iii) warrants to purchase up to 130,333 shares of Common Stock with an exercise price of $0.80 per share, each of such warrant is currently exercisable or exercisable within 60 days of October 3, 2022.